MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Decreased autoantibody production in IRF5-deficient MRL/lpr mice. by Kei Yasuda (606333)

CcnA mutation of Loop A decreases the interaction with the 5′ UTR of P2-<i>ctrA</i> mRNA and 5′ UTR of <i>gcrA</i> mRNA. by Wanassa Beroual (5314028)

The expression of 5-hmC was decreased in ESCC tissues and cell lines. by Xuejiao Shi (1684186)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

When there is information, (A) V challenge less and (B) R resist the same. by Aron Szekely (8286549)

Eliminations of dorsal projections in DOM and DOM-A downregulation were due to reduced number of sLNvs and decrease of PDF. by Zhenxing Liu (399809)

Fig 5 - by Charlotte Hennah (11868929)

Decreased clearance of IgAN patient IgA by CD89-expressing Kupffer cells. by Lijun Xu (195394)

“…(B) sCD89-IgA complexes in cell supernatant of (A) were detected by ELISA using A3 and anti-mouse IgA mAb, using 1 μg/mL human IgA binding to 5 μg/mL recCD89 as an internal control. …”

Chemokine CXCL1 is decreased in MyD88^-/- mice. by Rose Y. Reins (2586106)

Over-expression of DN VPS4 in HEK293T cells leads to increased extracellular α-synuclein and parallel decrease in lysosome. by Takafumi Hasegawa (18204)

“…<p><i>A</i>. αSYN-expressing HEK293T cells were co-transfected either with 3XFLAG-tagged wt-VPS4A or DN mutant (E228Q) VPS4A. …”

vFLIP and vCyclin decrease SMAD2 protein expression and desensitize TGF-β signaling. by Hong Seok Choi (121525)

“…<p>(A) SMAD2 expression was drastically decreased upon the expression of vFLIP or vCyclin in SLK cells. …”

DDX3 levels are not decreased in MCMV-infected cells. by Olha Puhach (9500132)

GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

“…<p>(<b>A</b>) The composite proton concentration-response curves show an enhanced sensitivity of the GluN2A(D731N)-containing receptors to proton compared to the WT NMDA receptors; the abscissa shows hydrogen ion activity. …”

Fig 9 - by Jianbo Jia (717814)

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

“…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”

Decreased type 1 IFN and enhanced MHV-68 loads in lungs of TLR2- and MyD88-deficient mice. by François Michaud (360245)

Antibody responses and FRT pathology are comparable between WT and <i>Bhlhe40</i>^<i>-/-</i> mice. by Miguel A. B. Mercado (17847533)

Decreased cell integrity and an increased number of intracellular membrane compartments in <i>ap1b1</i> mutant HCs. by Rachel Clemens Grisham (402043)

Exposure to trips and slips with increasing unpredictability while walking can improve balance recovery responses with minimum predictive gait alterations - Fig 5 by Yoshiro Okubo (589967)